NASDAQ: BMRN       Biomarin Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
126.61   +0.77 (0.61%)  121.67 - 128.615  862,399


Avg Volume (4 weeks):1,771,305
4 Weeks Range:103.08 - 128.77
4 Weeks Price Volatility (%):
52 Weeks Range:62.88 - 128.77
52 Weeks Price Volatility (%):
Average Price Target: 133.00
Price Target Upside/Downside: +6.39


No recent Headlines for this stock.

Business Background

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1767  4077  228  2992 

Top 10 Active Counters
 GNUS 3.60+1.29 
 NIO 9.345+1.435 
 LK 1.38-1.62 
 SOLO 3.17+0.84 
 WKHS 20.521+1.341 
 AAL 12.48-0.33 
 SQQQ 7.145-0.145 
 GE 6.825+0.085 
 PCG 9.46+0.43 
 AVP 5.60-0.05 
Partners & Brokers